Literature DB >> 20444703

miR-10b targets Tiam1: implications for Rac activation and carcinoma migration.

Charlotte H Moriarty1, Bryan Pursell, Arthur M Mercurio.   

Abstract

Understanding the mechanisms by which specific microRNAs regulate cell migration and invasion is a timely and significant problem in cancer cell biology. miR-10b is of interest in this regard because its expression is altered in breast and other cancers. Our analysis of potential miR-10b targets identified Tiam1 (T lymphoma invasion and metastasis 1), a guanidine exchange factor for Rac. We demonstrate, using an miR-10b synthetic precursor, expression vector, and antisense oligonucleotide, that miR-10b represses Tiam1 expression in breast carcinoma cells and that it interacts with the 3'-UTR of Tiam1. Consistent with the involvement of Tiam1 in cell motility, we observed that miR-10b suppresses the ability of breast carcinoma cells to migrate and invade. Importantly, we demonstrate that miR-10b also inhibits Tiam1-mediated Rac activation. These data provide a mechanism for the regulation of Tiam1-mediated Rac activation in breast cancer cells and need to be considered in the context of other reported functions for miR-10b.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20444703      PMCID: PMC2898316          DOI: 10.1074/jbc.M110.121012

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

Review 1.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

2.  Tiam1 overexpression potentiates heregulin-induced lymphoid enhancer factor-1/beta -catenin nuclear signaling in breast cancer cells by modulating the intercellular stability.

Authors:  L Adam; R K Vadlamudi; P McCrea; R Kumar
Journal:  J Biol Chem       Date:  2001-04-27       Impact factor: 5.157

3.  MicroRNA-10b and breast cancer metastasis.

Authors:  Harriet E Gee; Carme Camps; Francesca M Buffa; Stefano Colella; Helen Sheldon; Jonathan M Gleadle; Jiannis Ragoussis; Adrian L Harris
Journal:  Nature       Date:  2008-10-23       Impact factor: 49.962

4.  Activation of phosphoinositide 3-OH kinase by the alpha6beta4 integrin promotes carcinoma invasion.

Authors:  L M Shaw; I Rabinovitz; H H Wang; A Toker; A M Mercurio
Journal:  Cell       Date:  1997-12-26       Impact factor: 41.582

5.  A role for Rac in Tiam1-induced membrane ruffling and invasion.

Authors:  F Michiels; G G Habets; J C Stam; R A van der Kammen; J G Collard
Journal:  Nature       Date:  1995-05-25       Impact factor: 49.962

Review 6.  The role of the guanine nucleotide exchange factor Tiam1 in cellular migration, invasion, adhesion and tumor progression.

Authors:  Meghan E Minard; Lee-Su Kim; Janet E Price; Gary E Gallick
Journal:  Breast Cancer Res Treat       Date:  2004-03       Impact factor: 4.872

7.  MicroRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines.

Authors:  Yanyan Tian; Aiping Luo; Yiran Cai; Qin Su; Fang Ding; Hongyan Chen; Zhihua Liu
Journal:  J Biol Chem       Date:  2010-01-14       Impact factor: 5.157

8.  miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis.

Authors:  Christoph A Gebeshuber; Kurt Zatloukal; Javier Martinez
Journal:  EMBO Rep       Date:  2009-02-27       Impact factor: 8.807

9.  Rac downregulates Rho activity: reciprocal balance between both GTPases determines cellular morphology and migratory behavior.

Authors:  E E Sander; J P ten Klooster; S van Delft; R A van der Kammen; J G Collard
Journal:  J Cell Biol       Date:  1999-11-29       Impact factor: 10.539

10.  A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells.

Authors:  Ulrike Burk; Jörg Schubert; Ulrich Wellner; Otto Schmalhofer; Elizabeth Vincan; Simone Spaderna; Thomas Brabletz
Journal:  EMBO Rep       Date:  2008-05-16       Impact factor: 8.807

View more
  45 in total

1.  miR-21 and miR-31 converge on TIAM1 to regulate migration and invasion of colon carcinoma cells.

Authors:  Charisa L Cottonham; Satoshi Kaneko; Lan Xu
Journal:  J Biol Chem       Date:  2010-09-07       Impact factor: 5.157

2.  Combining miR-10b-Targeted Nanotherapy with Low-Dose Doxorubicin Elicits Durable Regressions of Metastatic Breast Cancer.

Authors:  Byunghee Yoo; Amol Kavishwar; Alana Ross; Ping Wang; Doris P Tabassum; Kornelia Polyak; Natalia Barteneva; Victoria Petkova; Pamela Pantazopoulos; Aseda Tena; Anna Moore; Zdravka Medarova
Journal:  Cancer Res       Date:  2015-09-10       Impact factor: 12.701

3.  MiR-182 is up-regulated and targeting Cebpa in hepatocellular carcinoma.

Authors:  Chenggang Wang; Ren Ren; Haolin Hu; Changjun Tan; Miao Han; Xiaolin Wang; Yun Zheng
Journal:  Chin J Cancer Res       Date:  2014-02       Impact factor: 5.087

4.  Human glioma growth is controlled by microRNA-10b.

Authors:  Galina Gabriely; Ming Yi; Ravi S Narayan; Johanna M Niers; Thomas Wurdinger; Jaime Imitola; Keith L Ligon; Santosh Kesari; Christine Esau; Robert M Stephens; Bakhos A Tannous; Anna M Krichevsky
Journal:  Cancer Res       Date:  2011-04-06       Impact factor: 12.701

5.  Roles for microRNAs in the regulation of cell adhesion molecules.

Authors:  Scott Valastyan; Robert A Weinberg
Journal:  J Cell Sci       Date:  2011-04-01       Impact factor: 5.285

Review 6.  The miR-10 microRNA precursor family.

Authors:  Disa Tehler; Nina Molin Høyland-Kroghsbo; Anders H Lund
Journal:  RNA Biol       Date:  2011-09-01       Impact factor: 4.652

Review 7.  The fundamental role of miR-10b in metastatic cancer.

Authors:  Patrick Sheedy; Zdravka Medarova
Journal:  Am J Cancer Res       Date:  2018-09-01       Impact factor: 6.166

Review 8.  Role of microRNAs in breast cancer.

Authors:  Ramesh Singh; Yin-Yuan Mo
Journal:  Cancer Biol Ther       Date:  2013-01-04       Impact factor: 4.742

Review 9.  Small molecule compounds targeting miRNAs for cancer therapy.

Authors:  Paloma Del C Monroig; Lu Chen; Shuxing Zhang; George A Calin
Journal:  Adv Drug Deliv Rev       Date:  2014-09-17       Impact factor: 15.470

Review 10.  The relevance of the TGF-β Paradox to EMT-MET programs.

Authors:  Chevaun D Morrison; Jenny G Parvani; William P Schiemann
Journal:  Cancer Lett       Date:  2013-03-05       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.